Jung Yun Julie Kang, MD, PhD
Assistant Professor of Therapeutic Radiology
Research & Publications
Biography
News
Research Summary
As an academic radiation oncologist, my research focuses on optimizing radiation therapy by harnessing technology and cutting-edge science to make cancer care safer and more effective. There have been great advances in radiation oncology which enable us to treat cancer with fewer side effects. I have published extensively on treatment deintensification, prognostication, toxicity, and personalizing therapy for head and neck and prostate cancers. In analyzing the clinical, biological, and demographic factors that influence cancer outcomes, we can improve health care quality for each individual as well as on the population level. I am actively involved in clinical trials and cooperative groups that aim to define and raise the standard of care through research and education. I have a particular interest in cancer disparities research and reducing barriers to care, serving on committees at Yale Cancer Center and national cooperative groups.
I have co-authored over fifty peer-reviewed original research articles, reviews, and book chapters. I am also interested in mentoring medical students and residents in comparative effectiveness research, health services research, and big data analytics related to head and neck and prostate cancers.
Research Interests
Head and Neck Neoplasms; Prostatic Neoplasms; Radiation; Clinical Trial; Mentoring
Selected Publications
- Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus‐associated oropharyngeal cancerKang J, Yu Y, Chen L, Zakeri K, Gelblum D, McBride S, Riaz N, Tsai C, Kriplani A, Hung T, Fetten J, Dunn L, Ho A, Boyle J, Ganly I, Singh B, Sherman E, Pfister D, Wong R, Lee N. Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus‐associated oropharyngeal cancer. CA A Cancer Journal For Clinicians 2022, 73: 164-197. PMID: 36305841, PMCID: PMC9992119, DOI: 10.3322/caac.21758.
- Oropharyngeal CarcinomaHusain Z, Kang J, Lee N, Poon I. Oropharyngeal Carcinoma. 2022, 15-25. DOI: 10.1007/978-3-030-99590-4_2.
- Larynx CancerFan D, Kang J, Yu Y, Cahlon O, Riaz N, Lee N. Larynx Cancer. 2022, 45-60. DOI: 10.1007/978-3-030-99590-4_4.
- Oropharyngeal Cancer Early Outcomes and Challenges During the COVID-19 PandemicKang J, Wu Y, Rybkin A, Yu Y, Chen L, Zakeri K, McBride S, Riaz N, Tsai C, Gelblum D, Wong R, Sherman E, Pfister D, Lee N. Oropharyngeal Cancer Early Outcomes and Challenges During the COVID-19 Pandemic. International Journal Of Radiation Oncology • Biology • Physics 2021, 111: e412. PMCID: PMC8536212, DOI: 10.1016/j.ijrobp.2021.07.1185.
- Dose and Volume De-Escalation for Elective Nodal Regions in Patients With Human Papillomavirus (HPV)-Positive Oropharyngeal Cancer (OPC) Undergoing Curative-Intent Concurrent Chemoradiation (CCRT)Tsai C, McBride S, Riaz N, Kang J, Spielsinger D, Waldenberg T, Yu Y, Chen L, Zakeri K, Wong R, Dunn L, Sherman E, Lee N. Dose and Volume De-Escalation for Elective Nodal Regions in Patients With Human Papillomavirus (HPV)-Positive Oropharyngeal Cancer (OPC) Undergoing Curative-Intent Concurrent Chemoradiation (CCRT). International Journal Of Radiation Oncology • Biology • Physics 2021, 111: s142-s143. DOI: 10.1016/j.ijrobp.2021.07.321.
- Concurrent carboplatin and paclitaxel definitive radiation therapy for locally advanced head and neck cancerHan J, Zakeri K, Raab G, Hesse J, Shamseddine A, Chen L, Yu Y, Kang J, McBride S, Riaz N, Tsai C, Gelblum D, Sherman E, Wong R, Michel L, Lee N. Concurrent carboplatin and paclitaxel definitive radiation therapy for locally advanced head and neck cancer. Head & Neck 2023, 45: 2207-2216. PMID: 37439286, PMCID: PMC10981461, DOI: 10.1002/hed.27456.
- Post-operative PET/CT improves the detection of early recurrence of squamous cell carcinomas of the oral cavityYu Y, Schöder H, Zakeri K, Chen L, Kang J, McBride S, Tsai C, Gelblum D, Boyle J, Cracchiolo J, Cohen M, Singh B, Ganly I, Patel S, Michel L, Dunn L, Sherman E, Pfister D, Wong R, Riaz N, Lee N. Post-operative PET/CT improves the detection of early recurrence of squamous cell carcinomas of the oral cavity. Oral Oncology 2023, 141: 106400. PMID: 37099979, PMCID: PMC10631462, DOI: 10.1016/j.oraloncology.2023.106400.
- Physician Graded Toxicity Profiles and Survival Outcomes among Patients with Non-Metastatic Oropharyngeal Carcinoma Treated with Proton Therapy vs. Intensity-Modulated Radiation TherapyYoussef I, Yoon J, Zakeri K, Cohen M, Wong R, Yu Y, Kang J, Gelblum D, McBride S, Sherman E, Dunn L, Cracchiolo J, Chen L, Lee N. Physician Graded Toxicity Profiles and Survival Outcomes among Patients with Non-Metastatic Oropharyngeal Carcinoma Treated with Proton Therapy vs. Intensity-Modulated Radiation Therapy. International Journal Of Radiation Oncology • Biology • Physics 2022, 114: e325-e326. DOI: 10.1016/j.ijrobp.2022.07.1399.
- Treatment Outcomes for Radiation Therapy with Concurrent Carboplatin and Paclitaxel for Locally Advanced Head and Neck CancerHan J, Zakeri K, Raab G, Chen L, Yu Y, Kang J, McBride S, Riaz N, Tsai C, Gelblum D, Sherman E, Wong R, Michel L, Lee N. Treatment Outcomes for Radiation Therapy with Concurrent Carboplatin and Paclitaxel for Locally Advanced Head and Neck Cancer. International Journal Of Radiation Oncology • Biology • Physics 2022, 114: e317. DOI: 10.1016/j.ijrobp.2022.07.1381.
- Peer Review of Head and Neck Cancer Planning Target Volumes in Radiation OncologyHesse J, Zakeri K, Chen L, Yu Y, Kang J, Riaz N, Tsai C, McBride S, Gelblum D, Lee N. Peer Review of Head and Neck Cancer Planning Target Volumes in Radiation Oncology. International Journal Of Radiation Oncology • Biology • Physics 2022, 114: e472-e473. DOI: 10.1016/j.ijrobp.2022.07.1729.
- Nasal Cavity and Paranasal Sinus TumorsFan M, Yu Y, Kang J, Lee N. Nasal Cavity and Paranasal Sinus Tumors. 2022, 87-98. DOI: 10.1007/978-3-030-99590-4_7.
- Outcomes and Toxicities of Nonmedullary Thyroid Tumors Treated with Proton Beam Radiation TherapyYoussef I, Yoon J, Mohamed N, Zakeri K, Press R, Yu Y, Kang J, Wong R, Tuttle R, Shaha A, Sherman E, Lee N. Outcomes and Toxicities of Nonmedullary Thyroid Tumors Treated with Proton Beam Radiation Therapy. International Journal Of Particle Therapy 2022, 9: 20-30. PMID: 36060412, PMCID: PMC9415751, DOI: 10.14338/ijpt-22-00005.1.
- Outcomes for Organ Preservation with Chemoradiation Therapy for T4 Larynx and Hypopharynx CancerEita A, Mohamed N, Rybkin A, Kang J, Fiasconaro M, Zhigang Z, Zakeri K, Yu Y, Sadaka E, Sherman E, Dunn L, Cracchiolo J, Wong R, Cohen M, Lee N. Outcomes for Organ Preservation with Chemoradiation Therapy for T4 Larynx and Hypopharynx Cancer. The Laryngoscope 2022, 133: 1138-1145. PMID: 35801573, PMCID: PMC10547133, DOI: 10.1002/lary.30279.
- Evaluation of Substantial Reduction in Elective Radiotherapy Dose and Field in Patients With Human Papillomavirus–Associated Oropharyngeal Carcinoma Treated With Definitive ChemoradiotherapyTsai CJ, McBride SM, Riaz N, Kang JJ, Spielsinger DJ, Waldenberg T, Gelblum D, Yu Y, Chen LC, Zakeri K, Wong RJ, Dunn L, Pfister DG, Sherman EJ, Lee NY. Evaluation of Substantial Reduction in Elective Radiotherapy Dose and Field in Patients With Human Papillomavirus–Associated Oropharyngeal Carcinoma Treated With Definitive Chemoradiotherapy. JAMA Oncology 2022, 8: 364-372. PMID: 35050342, PMCID: PMC8778604, DOI: 10.1001/jamaoncol.2021.6416.
- Peer Review of Head and Neck Cancer Planning Target Volumes in Radiation OncologyHesse J, Chen L, Yu Y, Kang J, Riaz N, Tsai C, McBride S, Gelblum D, Zakeri K, Lee N. Peer Review of Head and Neck Cancer Planning Target Volumes in Radiation Oncology. Advances In Radiation Oncology 2022, 7: 100917. PMID: 35647395, PMCID: PMC9133360, DOI: 10.1016/j.adro.2022.100917.
- Long-term Therapeutic and Functional Outcomes With Organ Preservation for T4 Larynx and Hypopharynx CancersRybkin A, Eita A, Kang J, Fiasconaro M, Zhang Z, Zakeri K, Yu Y, Chen L, Gelblum D, Tsai C, Riaz N, McBride S, Sherman E, Dunn L, Ho A, Cohen M, Cracchiolo J, Pfister D, Wong R, Lee N. Long-term Therapeutic and Functional Outcomes With Organ Preservation for T4 Larynx and Hypopharynx Cancers. International Journal Of Radiation Oncology • Biology • Physics 2021, 111: e365-e366. DOI: 10.1016/j.ijrobp.2021.07.1084.
- The effect of short radiation treatment breaks on chemo‐radiotherapy for oropharyngeal cancersRybkin A, Kang JJ, Lee A, Kitpanit S, Fan M, Mohamed N, Cartano O, Zakeri K, Gelblum D, Sherman E, Dunn L, Boyle J, Wong R, Chen L, Yu Y, McBride SM, Tsai CJ, Riaz N, Lee NY. The effect of short radiation treatment breaks on chemo‐radiotherapy for oropharyngeal cancers. Head & Neck 2021, 43: 3796-3809. PMID: 34585792, PMCID: PMC9414892, DOI: 10.1002/hed.26879.
- TERT Promoter Mutations Are Enriched in Oral Cavity Cancers and Associated With Locoregional RecurrenceYu Y, Fan D, Song X, Zakeri K, Chen L, Kang J, McBride S, Tsai CJ, Dunn L, Sherman E, Katabi N, Dogan S, Cracchiolo J, Cohen M, Boyle JO, Lee M, Valero C, Wang J, Wong R, Morris L, Riaz N, Lee N. TERT Promoter Mutations Are Enriched in Oral Cavity Cancers and Associated With Locoregional Recurrence. JCO Precision Oncology 2021, 5: 1259-1269. PMID: 34381934, PMCID: PMC8345918, DOI: 10.1200/po.20.00515.
- Proton radiotherapy for recurrent or metastatic sarcoma with palliative quad shotLee A, Kang J, Bernstein H, Marqueen K, Neal B, Kelly C, Dickson M, Tsai C, Tap W, Singer S, Alektiar K, Lee N. Proton radiotherapy for recurrent or metastatic sarcoma with palliative quad shot. Cancer Medicine 2021, 10: 4221-4227. PMID: 34085781, PMCID: PMC8267151, DOI: 10.1002/cam4.3646.
- Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation TherapyLi X, Kitpanit S, Lee A, Mah D, Sine K, Sherman EJ, Dunn LA, Michel LS, Fetten J, Zakeri K, Yu Y, Chen L, Kang JJ, Gelblum DY, McBride SM, Tsai CJ, Riaz N, Lee NY. Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy. JAMA Network Open 2021, 4: e2113205. PMID: 34143193, PMCID: PMC8214161, DOI: 10.1001/jamanetworkopen.2021.13205.
- Postoperative PET/CT for detection of early recurrence (ER) after surgery for squamous cell carcinomas (SCC) of the oral cavity (OC).Yu Y, Schöder H, Kang J, McBride S, Tsai C, Chen L, Zakeri K, Gelblum D, Boyle J, Cracchiolo J, Cohen M, Singh B, Ganly I, Patel S, Michel L, Dunn L, Pfister D, Wong R, Riaz N, Lee N. Postoperative PET/CT for detection of early recurrence (ER) after surgery for squamous cell carcinomas (SCC) of the oral cavity (OC). Journal Of Clinical Oncology 2021, 39: 6060-6060. DOI: 10.1200/jco.2021.39.15_suppl.6060.
- The 30 ROC trial: Precision intra-treatment imaging guiding major radiation reduction in human papillomavirus related oropharyngeal cancer.Lee N, Sherman E, Schöder H, McBride S, Yu Y, Kang J, Tsai C, Gelblum D, Boyle J, Singh B, Cohen M, Cracchiolo J, Ganly I, Dunn L, Kriplani A, Fetten J, Michel L, Wong R, Pfister D, Riaz N. The 30 ROC trial: Precision intra-treatment imaging guiding major radiation reduction in human papillomavirus related oropharyngeal cancer. Journal Of Clinical Oncology 2021, 39: 6019-6019. DOI: 10.1200/jco.2021.39.15_suppl.6019.
- Any day, split halfway: Flexibility in scheduling high‐dose cisplatin—A large retrospective review from a high‐volume cancer centerKang JJ, Tchekmedyian V, Mohammed N, Rybkin A, Kitpanit S, Fan M, Wang H, Lobaugh SM, Zhang Z, Lee A, Chen L, Yu Y, Zakeri K, Gelblum DY, Riaz N, McBride SM, Tsai CJ, Cohen MA, Cracchiolo JR, Morris LG, Singh B, Patel S, Ganly I, Boyle JO, Wong RJ, Eng J, Zhi WI, Ng K, Ho AL, Dunn LA, Michel L, Fetten JV, Pfister DG, Lee NY, Sherman EJ. Any day, split halfway: Flexibility in scheduling high‐dose cisplatin—A large retrospective review from a high‐volume cancer center. International Journal Of Cancer 2021, 149: 139-148. PMID: 33586179, PMCID: PMC9380235, DOI: 10.1002/ijc.33518.
- Outcomes and prognostic factors of major salivary gland tumors treated with proton beam radiation therapyZakeri K, Wang H, Kang JJ, Lee A, Romesser P, Mohamed N, Gelblum D, Sherman E, Dunn L, Boyle J, Wong R, Chen L, Yu Y, Tsai CJ, McBride SM, Riaz N, Lee N. Outcomes and prognostic factors of major salivary gland tumors treated with proton beam radiation therapy. Head & Neck 2021, 43: 1056-1062. PMID: 33606323, PMCID: PMC9371938, DOI: 10.1002/hed.26563.
- Impact of Telemedicine on Patient Satisfaction and Perceptions of Care Quality in Radiation Oncology.Shaverdian N, Gillespie EF, Cha E, Kim SY, Benvengo S, Chino F, Kang JJ, Li Y, Atkinson TM, Lee N, Washington CM, Cahlon O, Gomez DR. Impact of Telemedicine on Patient Satisfaction and Perceptions of Care Quality in Radiation Oncology. Journal Of The National Comprehensive Cancer Network 2021, 19: 1174-1180. PMID: 33395627, PMCID: PMC8254817, DOI: 10.6004/jnccn.2020.7687.
- Split High-Dose Cisplatin: An Alternate High-Dose Cisplatin Administration Schedule for Definitive Chemoradiation in Oropharyngeal CancerKang J, Tchekmedyian V, Fan M, Wang H, Kitpanit S, Mohamed N, Rybkin A, Lee A, Chen L, Yu Y, Riaz N, McBride S, Tsai C, Ho A, Dunn L, Fetten J, Pfister D, Zhang Z, Lee N, Sherman E. Split High-Dose Cisplatin: An Alternate High-Dose Cisplatin Administration Schedule for Definitive Chemoradiation in Oropharyngeal Cancer. International Journal Of Radiation Oncology • Biology • Physics 2020, 108: e797-e798. DOI: 10.1016/j.ijrobp.2020.07.279.
- Radiation Treatment Breaks: Are They Detrimental to Outcomes for Oropharyngeal Carcinoma Treated with Definitive Chemoradiation?Rybkin A, Kang J, Lee A, Kitpanit S, Fan M, Mohamed N, Cartano O, Dunn L, Sherman E, Wong R, Tsai C, McBride S, Yu Y, Chen L, Zakeri K, Riaz N, Lee N. Radiation Treatment Breaks: Are They Detrimental to Outcomes for Oropharyngeal Carcinoma Treated with Definitive Chemoradiation? International Journal Of Radiation Oncology • Biology • Physics 2020, 108: e851-e852. DOI: 10.1016/j.ijrobp.2020.07.409.
- The 3 Bs of cancer care amid the COVID‐19 pandemic crisis: “Be safe, be smart, be kind”—A multidisciplinary approach increasing the use of radiation and embracing telemedicine for head and neck cancerKang JJ, Wong RJ, Sherman EJ, Rybkin A, McBride SM, Riaz N, Tsai CJ, Yu Y, Chen L, Zakeri K, Gelblum DY, Gillespie EF, Cohen MA, Cracchiolo JR, Ganly I, Patel S, Singh B, Boyle JO, Roman BR, Morris LG, Shaha AR, Dunn LA, Ho AL, Fetten JV, Shah JP, Pfister DG, Lee NY. The 3 Bs of cancer care amid the COVID‐19 pandemic crisis: “Be safe, be smart, be kind”—A multidisciplinary approach increasing the use of radiation and embracing telemedicine for head and neck cancer. Cancer 2020, 126: 4092-4104. PMID: 32639615, PMCID: PMC7361524, DOI: 10.1002/cncr.33031.
- Beyond reirradiation: Efficacy and safety of three or more courses of radiation for head and neck malignanciesXu AJ, Luo L, Leeman JE, Romesser PB, Spielsinger D, Sabol C, Waldenberg T, Brinkman T, Riaz N, McBride S, Kang J, Lee N, Tsai CJ. Beyond reirradiation: Efficacy and safety of three or more courses of radiation for head and neck malignancies. Clinical And Translational Radiation Oncology 2020, 23: 30-34. PMID: 32382663, PMCID: PMC7200775, DOI: 10.1016/j.ctro.2020.04.009.
- Predictors of Immunotherapy Response in Head and Neck Cancer: Per Lesion Analysis of a Prospective Randomized Trial with NivolumabYu Y, Chen L, Riaz N, Tsai C, Kang J, Sherman E, Lee N, McBride S. Predictors of Immunotherapy Response in Head and Neck Cancer: Per Lesion Analysis of a Prospective Randomized Trial with Nivolumab. International Journal Of Radiation Oncology • Biology • Physics 2020, 106: 1131. DOI: 10.1016/j.ijrobp.2019.11.359.
- Changing the Paradigm in HPV-Negative Oropharyngeal Cancer: Deintensification Based on Low Risk of Locoregional RelapseKang J, Cartano O, Fan D, Fan M, Wang H, Kitpanit S, Lee A, Gelblum D, Sherman E, Dunn L, Cohen M, Boyle J, Wong R, Tsai C, McBride S, Zakeri K, Chen L, Yu Y, Riaz N, Lee N. Changing the Paradigm in HPV-Negative Oropharyngeal Cancer: Deintensification Based on Low Risk of Locoregional Relapse. International Journal Of Radiation Oncology • Biology • Physics 2020, 106: 1151-1152. DOI: 10.1016/j.ijrobp.2019.11.229.
- Radical Reduction of Radiation Therapy Dose Prescription for Elective Treatment Areas in Human Papillomavirus (HPV) - Associated Oropharyngeal Carcinoma (OPC)Tsai C, McBride S, Riaz N, Kang J, Yu Y, Chen L, Gelblum D, Wong R, Boyle J, Dunn L, Sherman E, Pfister D, Lee N. Radical Reduction of Radiation Therapy Dose Prescription for Elective Treatment Areas in Human Papillomavirus (HPV) - Associated Oropharyngeal Carcinoma (OPC). International Journal Of Radiation Oncology • Biology • Physics 2020, 106: 1143-1144. DOI: 10.1016/j.ijrobp.2019.11.209.
- Long-Term Update of Proton Beam Re-Irradiation for Recurrent Head and Neck CancerLee A, Kitpanit S, Romesser P, Sine K, Kang J, Fan D, Fan M, Wang H, Li X, Sherman E, Michel L, Boyle J, Wong R, Zakeri K, Chen L, Yu Y, McBride S, Riaz N, Tsai C, Lee N. Long-Term Update of Proton Beam Re-Irradiation for Recurrent Head and Neck Cancer. International Journal Of Radiation Oncology • Biology • Physics 2020, 106: 1181. DOI: 10.1016/j.ijrobp.2019.11.140.
- Profiling the Spatial Composition of the Hypoxic Tumor-Immune Microenvironment through Multiplex Immunohistochemistry in a Prospective cohort of HPV Associated Oropharynx CancerChen L, Hollmann T, Li Y, Katabi N, Shah R, Yu Y, Kang J, Tsai C, McBride S, Lee N, Riaz N. Profiling the Spatial Composition of the Hypoxic Tumor-Immune Microenvironment through Multiplex Immunohistochemistry in a Prospective cohort of HPV Associated Oropharynx Cancer. International Journal Of Radiation Oncology • Biology • Physics 2020, 106: 1133. DOI: 10.1016/j.ijrobp.2019.11.363.
- Clinical Outcomes and Toxicities in Oropharyngeal Cancer (OPC) Patients Treated with Proton Therapy: A Single Institutional ExperienceKitpanit S, Lee A, Fan D, Fan M, Wang H, Mohamed N, Spielsinger D, Gelblum D, Sherman E, Dunn L, Boyle J, Wong R, Cohen M, Kang J, Tsai C, McBride S, Zakeri K, Chen L, Yu Y, Riaz N, Lee N. Clinical Outcomes and Toxicities in Oropharyngeal Cancer (OPC) Patients Treated with Proton Therapy: A Single Institutional Experience. International Journal Of Radiation Oncology • Biology • Physics 2020, 106: 1152-1153. DOI: 10.1016/j.ijrobp.2019.11.231.
- Outcomes of Major Salivary Gland Tumors Treated with Proton Beam Radiation TherapyZakeri K, Wang H, Kang J, Lee A, Gelblum D, Sherman E, Dunn L, Boyle J, Wong R, Chen L, Yu Y, Tsai C, McBride S, Riaz N, Lee N. Outcomes of Major Salivary Gland Tumors Treated with Proton Beam Radiation Therapy. International Journal Of Radiation Oncology • Biology • Physics 2020, 106: 1194. DOI: 10.1016/j.ijrobp.2019.11.105.
- Proton Therapy for Non-Skull Base Head and Neck Adenoid Cystic CarcinomaLee A, Kitpanit S, Marqueen K, Sine K, Kang J, Fan D, Fan M, Wang H, Li X, Gelblum D, Michel L, Boyle J, Wong R, Zakeri K, Chen L, Yu Y, McBride S, Riaz N, Tsai C, Lee N. Proton Therapy for Non-Skull Base Head and Neck Adenoid Cystic Carcinoma. International Journal Of Radiation Oncology • Biology • Physics 2020, 106: 1196. DOI: 10.1016/j.ijrobp.2019.11.109.
- CLO20-041: Prognostic Factors in Major Salivary Gland Tumors Treated with Adjuvant Radiation TherapyKang J, Verma H, Zakeri K, Wang H, Fan D, Fan M, Lee A, Kitpanit S, Chen L, Yu Y, Tsai C, McBride S, Riaz N, Gelblum D, Ho A, Sherman E, Dunn L, Boyle J, Wong R, Ganly I, Lee N. CLO20-041: Prognostic Factors in Major Salivary Gland Tumors Treated with Adjuvant Radiation Therapy. Journal Of The National Comprehensive Cancer Network 2020, 18: clo20-041. DOI: 10.6004/jnccn.2019.7507.
- Last-line local treatment with the Quad Shot regimen for previously irradiated head and neck cancersFan D, Kang JJ, Fan M, Wang H, Lee A, Yu Y, Chen L, Tsai C, McBride SM, Riaz N, Gelblum DY, Neal BP, Fetten J, Dunn LA, Michel LS, Boyle JO, Cohen MA, Roman BR, Ganly I, Singh B, Wong RJ, Sherman EJ, Lee NY. Last-line local treatment with the Quad Shot regimen for previously irradiated head and neck cancers. Oral Oncology 2020, 104: 104641. PMID: 32182548, PMCID: PMC8480112, DOI: 10.1016/j.oraloncology.2020.104641.
- Temporal Lobe Necrosis in Head and Neck Cancer Patients after Proton Therapy to the Skull BaseKitpanit S, Lee A, Pitter KL, Fan D, Chow JCH, Neal B, Han Z, Fox P, Sine K, Mah D, Dunn LA, Sherman EJ, Michel L, Ganly I, Wong RJ, Boyle JO, Cohen MA, Singh B, Brennan CW, Gavrilovic IT, Hatzoglou V, O'Malley B, Zakeri K, Yu Y, Chen L, Gelblum DY, Kang JJ, McBride SM, Tsai CJ, Riaz N, Lee NY. Temporal Lobe Necrosis in Head and Neck Cancer Patients after Proton Therapy to the Skull Base. International Journal Of Particle Therapy 2020, 6: 17-28. PMID: 32582816, PMCID: PMC7302730, DOI: 10.14338/ijpt-20-00014.1.
- Outcomes and toxicities of definitive radiotherapy and reirradiation using 3‐dimensional conformal or intensity‐modulated (pencil beam) proton therapy for patients with nasal cavity and paranasal sinus malignanciesFan M, Kang JJ, Lee A, Fan D, Wang H, Kitpanit S, Fox P, Sine K, Mah D, McBride SM, Tsai CJ, Riaz N, Dunn LA, Sherman EJ, Michel L, Singh B, Ganly I, Wong RJ, Boyle JO, Cohen MA, Lee NY. Outcomes and toxicities of definitive radiotherapy and reirradiation using 3‐dimensional conformal or intensity‐modulated (pencil beam) proton therapy for patients with nasal cavity and paranasal sinus malignancies. Cancer 2020, 126: 1905-1916. PMID: 32097507, PMCID: PMC7304541, DOI: 10.1002/cncr.32776.
- Platinum‐based regimens versus cetuximab in definitive chemoradiation for human papillomavirus‐unrelated head and neck cancerBeckham TH, Barney C, Healy E, Wolfe AR, Branstetter A, Yaney A, Riaz N, McBride SM, Tsai CJ, Kang J, Yu Y, Chen L, Sherman E, Dunn L, Pfister DG, Tan J, Rupert R, Bonomi M, Zhang Z, Lobaugh SM, Grecula JC, Mitchell DL, Wobb JL, Miller ED, Blakaj DM, Diavolitsis VM, Lee N, Bhatt AD. Platinum‐based regimens versus cetuximab in definitive chemoradiation for human papillomavirus‐unrelated head and neck cancer. International Journal Of Cancer 2019, 147: 107-115. PMID: 31609479, DOI: 10.1002/ijc.32736.
- Outcomes of multimodal therapy in a large series of patients with anaplastic thyroid cancerFan D, Ma J, Bell AC, Groen AH, Olsen KS, Lok BH, Leeman JE, Anderson E, Riaz N, McBride S, Ganly I, Shaha AR, Sherman EJ, Tsai CJ, Kang JJ, Lee NY. Outcomes of multimodal therapy in a large series of patients with anaplastic thyroid cancer. Cancer 2019, 126: 444-452. PMID: 31593317, PMCID: PMC7302673, DOI: 10.1002/cncr.32548.
- TERT Promoter Mutations Among Oral Cavity Cancers: A Pattern of Failure AnalysisYu Y, Fan D, Song X, Chen L, Kang J, Tsai C, McBride S, Sherman E, Fetten J, Dunn L, Lee N, Riaz N. TERT Promoter Mutations Among Oral Cavity Cancers: A Pattern of Failure Analysis. International Journal Of Radiation Oncology • Biology • Physics 2019, 105: e408-e409. DOI: 10.1016/j.ijrobp.2019.06.1604.
- Last-line Treatment with the Quad Shot Regimen for Previously Irradiated Head and Neck CancersFan D, Fan M, Wang H, Lee A, Yu Y, Chen L, Bernstein M, Tsai C, McBride S, Riaz N, Mueller B, Gelblum D, Fetten J, Dunn L, Sherman E, Lee N, Kang J. Last-line Treatment with the Quad Shot Regimen for Previously Irradiated Head and Neck Cancers. International Journal Of Radiation Oncology • Biology • Physics 2019, 105: e402. DOI: 10.1016/j.ijrobp.2019.06.1589.
- Proton Radiotherapy for Recurrent or Metastatic Sarcoma with Palliative Quad Shot and SBRTLee A, Bernstein H, Kelly C, Dickson M, Tsai C, Kang J, Tap W, Lee N. Proton Radiotherapy for Recurrent or Metastatic Sarcoma with Palliative Quad Shot and SBRT. International Journal Of Radiation Oncology • Biology • Physics 2019, 105: e808. DOI: 10.1016/j.ijrobp.2019.06.2516.
- Predictors of Early Response to Immunotherapy in Head and Neck Cancer: A Secondary Clinical and Radiomic Analysis of a Prospective Randomized Trial with NivolumabYu Y, Chen L, Riaz N, Kang J, Thor M, Veeraraghavan H, Apte A, Tsai C, Deasy J, Sherman E, Lee N, McBride S. Predictors of Early Response to Immunotherapy in Head and Neck Cancer: A Secondary Clinical and Radiomic Analysis of a Prospective Randomized Trial with Nivolumab. International Journal Of Radiation Oncology • Biology • Physics 2019, 105: s211. DOI: 10.1016/j.ijrobp.2019.06.286.
- Timing of surgery and adjuvant radiation therapy for sinonasal malignancies: Effect of surgical approachXiao R, Joshi RR, Husain Q, Cracchiolo JR, Lee N, Tsai J, Yu Y, Chen L, Kang JJ, McBride S, Riaz N, Roman BR, Ganly I, Tabar V, Gray ST, Cohen MA. Timing of surgery and adjuvant radiation therapy for sinonasal malignancies: Effect of surgical approach. Head & Neck 2019, 41: 3551-3563. PMID: 31294897, PMCID: PMC6742559, DOI: 10.1002/hed.25873.
- A retrospective analysis of cisplatin dosing strategies when used with radiation on outcomes in head and neck squamous cell carcinoma of the oropharynx.Tchekmedyian V, Ho A, Dunn L, Fetten J, Pfister D, Lobaugh S, Zhang Z, Kang J, Chen L, Riaz N, McBride S, Yu Y, Tsai C, Lee N, Sherman E. A retrospective analysis of cisplatin dosing strategies when used with radiation on outcomes in head and neck squamous cell carcinoma of the oropharynx. Journal Of Clinical Oncology 2019, 37: 6079-6079. DOI: 10.1200/jco.2019.37.15_suppl.6079.
- Predictors of early immunotherapy response in head and neck cancer: Per lesion analysis of a prospective randomized trial with nivolumab.Yu Y, Chen L, Riaz N, Kang J, Tsai C, Sherman E, Lee N, McBride S. Predictors of early immunotherapy response in head and neck cancer: Per lesion analysis of a prospective randomized trial with nivolumab. Journal Of Clinical Oncology 2019, 37: 6041-6041. DOI: 10.1200/jco.2019.37.15_suppl.6041.
- Trends and Disparities of Proton Therapy Use among Patients with Head and Neck Cancer: Analysis from the National Cancer Database (2005-14)Lee A, Kang J, Yu Y, McBride S, Riaz N, Cohen M, Sherman E, Michel L, Lee N, Tsai CJ. Trends and Disparities of Proton Therapy Use among Patients with Head and Neck Cancer: Analysis from the National Cancer Database (2005-14). International Journal Of Particle Therapy 2019, 5: 1-10. PMID: 31773036, PMCID: PMC6871620, DOI: 10.14338/ijpt-19-00051.1.
- First Postprostatectomy Ultrasensitive Prostate-specific Antigen Predicts Survival in Patients with High-risk Prostate Cancer PathologyKang JJ, Reiter RE, Steinberg ML, King CR. First Postprostatectomy Ultrasensitive Prostate-specific Antigen Predicts Survival in Patients with High-risk Prostate Cancer Pathology. European Urology Oncology 2018, 1: 378-385. PMID: 31158076, DOI: 10.1016/j.euo.2018.07.008.
- Focal multimodality radiation therapy: A promising treatment for recalcitrant Darier diseaseRodriguez L, Kazemi T, Cheng C, Kang J, Beron P, Kozma B, Gee S. Focal multimodality radiation therapy: A promising treatment for recalcitrant Darier disease. Dermatologic Therapy 2018, 31: e12641. PMID: 30028557, DOI: 10.1111/dth.12641.
- Treatment of Bony and Soft Tissue Sarcomas by Radiation TherapyKang J, Selch M, Gage D. Treatment of Bony and Soft Tissue Sarcomas by Radiation Therapy. 2018, 293-301. DOI: 10.1142/9789813236332_0038.
- Whole Versus Partial Bladder RadiationKang J, Steinberg M, Kupelian P, Alexander S, King C. Whole Versus Partial Bladder Radiation. American Journal Of Clinical Oncology 2018, 41: 107-114. PMID: 26535994, DOI: 10.1097/coc.0000000000000237.
- Wrong to be RightKang JJ, Reiter RE, Kummer N, DeKernion J, Steinberg ML, King CR. Wrong to be Right. American Journal Of Clinical Oncology 2018, 41: 1-5. PMID: 26237192, PMCID: PMC6946377, DOI: 10.1097/coc.0000000000000216.
- Pelvic Nodal Dosing With Registration to the Prostate: Implications for High-Risk Prostate Cancer Patients Receiving Stereotactic Body Radiation TherapyKishan AU, Lamb JM, Jani SS, Kang JJ, Steinberg ML, King CR. Pelvic Nodal Dosing With Registration to the Prostate: Implications for High-Risk Prostate Cancer Patients Receiving Stereotactic Body Radiation Therapy. International Journal Of Radiation Oncology • Biology • Physics 2015, 91: 832-839. PMID: 25752398, DOI: 10.1016/j.ijrobp.2014.11.035.
- Ultrasensitive Prostate Specific Antigen after Prostatectomy Reliably Identifies Patients Requiring Postoperative RadiotherapyKang JJ, Reiter RE, Steinberg ML, King CR. Ultrasensitive Prostate Specific Antigen after Prostatectomy Reliably Identifies Patients Requiring Postoperative Radiotherapy. Journal Of Urology 2014, 193: 1532-1538. PMID: 25463990, PMCID: PMC4527538, DOI: 10.1016/j.juro.2014.11.017.
- High-Dose Radiation to the Subventricular Zone Does Not Alter the Patterns of Recurrence in GBKang J, Selch M, Kupelian P, Cloughesy T, Lee P. High-Dose Radiation to the Subventricular Zone Does Not Alter the Patterns of Recurrence in GB. International Journal Of Radiation Oncology • Biology • Physics 2014, 90: s294. DOI: 10.1016/j.ijrobp.2014.05.991.
- Ultra-Sensitive PSA Following Prostatectomy Reliably Identifies Patients Requiring Postoperative Radiation TherapyKang J, Reiter R, Steinberg M, King C. Ultra-Sensitive PSA Following Prostatectomy Reliably Identifies Patients Requiring Postoperative Radiation Therapy. International Journal Of Radiation Oncology • Biology • Physics 2014, 90: s130-s131. DOI: 10.1016/j.ijrobp.2014.05.578.
- In Reply to Sharma et alLee P, Kang J. In Reply to Sharma et al. International Journal Of Radiation Oncology • Biology • Physics 2013, 87: 631-632. PMID: 24138906, DOI: 10.1016/j.ijrobp.2013.07.027.
- Definitive Chemoradiation in Bladder Cancer: Whole Bladder Versus Partial Bladder Image Guided IMRTKang J, Alexander S, Steinberg M, King C. Definitive Chemoradiation in Bladder Cancer: Whole Bladder Versus Partial Bladder Image Guided IMRT. International Journal Of Radiation Oncology • Biology • Physics 2013, 87: s397. DOI: 10.1016/j.ijrobp.2013.06.1043.
- Brugada electrocardiographic pattern in carbon monoxide poisoningPalaniswamy C, Aronow W, Sugunaraj J, Kang J, Kar K, Kalra A. Brugada electrocardiographic pattern in carbon monoxide poisoning. Archives Of Medical Science 2013, 9: 377-380. PMID: 23671453, PMCID: PMC3648833, DOI: 10.5114/aoms.2013.34538.
- Radiation of Potential Local Cancer Stem Cell Niches Improves Survival of Patients With Glioblastoma MultiformeKang J, Selch M, Cloughesy T, Kupelian P, Pajonk F, Wang J, Agazaryan N, Lee P. Radiation of Potential Local Cancer Stem Cell Niches Improves Survival of Patients With Glioblastoma Multiforme. International Journal Of Radiation Oncology • Biology • Physics 2012, 84: s6-s7. DOI: 10.1016/j.ijrobp.2012.07.023.
- Brugada Electrocardiographic Pattern in Carbon Monoxide PoisoningSugunaraj J, Kang J, Aronow W, Kar K, Palaniswamy C, Most J. Brugada Electrocardiographic Pattern in Carbon Monoxide Poisoning. CHEST Journal 2011, 140: 35a-35b. DOI: 10.1378/chest.1119956.
- The Collecting Duct Is the Major Source of Prorenin in DiabetesKang J, Toma I, Sipos A, Meer E, Vargas S, Peti-Peterdi J. The Collecting Duct Is the Major Source of Prorenin in Diabetes. Hypertension 2008, 51: 1597-1604. PMID: 18413493, PMCID: PMC2398652, DOI: 10.1161/hypertensionaha.107.107268.
- Macula densa cells detect altered tissue metabolism via succinate and GPR91Vargas S, Toma I, Kang J, Hanner F, Peti‐Peterdi J. Macula densa cells detect altered tissue metabolism via succinate and GPR91. The FASEB Journal 2008, 22: 761.17-761.17. DOI: 10.1096/fasebj.22.1_supplement.761.17.
- (Pro)renin Receptor Activation Causes Acute Production of Macula Densa ProstaglandinsMeer E, Kang J, Vargas S, Toma I, Peti‐Peterdi J. (Pro)renin Receptor Activation Causes Acute Production of Macula Densa Prostaglandins. The FASEB Journal 2008, 22: 761.29-761.29. DOI: 10.1096/fasebj.22.1_supplement.761.29.
- Advances in renal (patho)physiology using multiphoton microscopySipos A, Toma I, Kang J, Rosivall L, Peti-Peterdi J. Advances in renal (patho)physiology using multiphoton microscopy. Kidney International 2007, 72: 1188-1191. PMID: 17667980, PMCID: PMC2424113, DOI: 10.1038/sj.ki.5002461.
- GPR91 triggers paracrine signaling in the JGAToma I, Kang J, Bansal E, Sipos A, McCulloch F, Peti‐Peterdi J. GPR91 triggers paracrine signaling in the JGA. The FASEB Journal 2007, 21: a498-a498. DOI: 10.1096/fasebj.21.5.a498-b.
- ATP‐mediated intercellular calcium wave in renal (juxta)glomerular endothelial cells (GENC)Bansal E, Toma I, Kang J, Peti‐Peterdi J. ATP‐mediated intercellular calcium wave in renal (juxta)glomerular endothelial cells (GENC). The FASEB Journal 2007, 21: a499-a499. DOI: 10.1096/fasebj.21.5.a499-c.